Bibliometric analysis reveals trends in antiangiogenic therapy outcomes for colorectal cancer, indicating global collaborations and evolving clinical strategies.
Key Points
Colorectal cancer shows over 1.9 million diagnoses per year, highlighting its global health impact.
The research exhibits a 13.65% annual growth rate in antiangiogenic studies from 1996 to 2024.
China leads in publications on antiangiogenic therapy, contributing 20.5% of the global output.
Results emphasize a transition from VEGF studies to targeted strategies aimed at the tumor microenvironment.